JPL Wealth Management
LGND icon

JPL Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History

JPL Wealth Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25K Sell
80
-166
-67% -$49.1K 0.01% 315
2026
Q2 		$77.8K Hold
246
– – 0.02% 200
2026
Q1 		$49.1K Buy
+246
New +$48.7K 0.01% 244
2025
Q4 		– Sell
-296
Closed -$52.4K – 668
2025
Q3 		$52.4K Buy
+296
New +$44K 0.01% 245

Other funds holding LGND

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

JPL Wealth Management's LGND Position: Q3 2026 in Review

JPL Wealth Management reduced its Ligand Pharmaceuticals (LGND) stake by 67% in Q3 2026, selling an estimated $49.1K and leaving 80 shares worth $25K. The position accounts for 0.01% of the portfolio, ranked #315.

JPL Wealth Management first reported a position in LGND in Q3 2025 and has held it in 4 quarters since. The position peaked at $77.8K in Q2 2026. 348 funds tracked by Wall St. Rank hold LGND as of Q3 2026.

  • JPL Wealth Management held 80 shares of Ligand Pharmaceuticals worth $25K as of Q3 2026.
  • JPL Wealth Management sold 166 Ligand Pharmaceuticals shares in Q3 2026, an estimated $49.1K.
  • Ligand Pharmaceuticals made up 0.01% of JPL Wealth Management's portfolio in Q3 2026, its #315 holding.
  • JPL Wealth Management first reported a position in Ligand Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • JPL Wealth Management's Ligand Pharmaceuticals position peaked at $77.8K in Q2 2026.
  • 348 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.

Based on JPL Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.